APA citiranje

Kumar, D., Kandl, C., Hamilton, C. D., Shnayder, Y., Tsue, T. T., Kakarala, K., . . . Thomas, S. M. (2015). Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti–Hepatocyte Growth Factor Antibody Ficlatuzumab. JAMA Otolaryngol Head Neck Surg.

Citação norma Chicago

Kumar, Dhruv, et al. "Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti–Hepatocyte Growth Factor Antibody Ficlatuzumab." JAMA Otolaryngol Head Neck Surg 2015.

MLA citiranje

Kumar, Dhruv, et al. "Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti–Hepatocyte Growth Factor Antibody Ficlatuzumab." JAMA Otolaryngol Head Neck Surg 2015.